LFMD LifeMD Inc
- Stocks
- Healthcare
- NASDAQ: LFMD
Price (delayed)
$5.62
Market cap
$266.49M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.2
Enterprise value
$252.31M
Relative Growth:
Rel. Growth:
81
Relative Strength:
Rel. Strength:
14
Relative Valuation:
Rel. Valuation:
34
Relative Profitability:
Rel. Profitability:
37
LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordable
Highlights
LifeMD's net income has surged by 75% YoY and by 45% QoQ
The EPS has soared by 71% YoY and by 39% from the previous quarter
The debt has declined by 12% since the previous quarter but it is up by 6% year-on-year
The quick ratio has contracted by 14% YoY and by 5% from the previous quarter
Key stats
What are the main financial stats of LFMD
Market
Valuations
Earnings
Shares outstanding
47.42M
Market cap
$266.49M
Enterprise value
$252.31M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.02
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
28.43
EV/Sales
1.03
Revenue
$245.56M
Gross profit
$215.05M
Operating income
-$2.03M
Net income
-$5.93M
EBIT
-$3.06M
EBITDA
$8.87M
Free cash flow
$6.7M
Per share
Balance sheet
Liquidity
EPS
-$0.2
EPS diluted
-$0.2
Free cash flow per share
$0.15
Book value per share
-$0.04
Revenue per share
$5.53
TBVPS
$1.28
Total assets
$73.56M
Total liabilities
$73.18M
Debt
$22.05M
Equity
-$1.78M
Working capital
-$14.51M
Debt to equity
-12.37
Current ratio
0.77
Quick ratio
0.69
Net debt/EBITDA
-1.6
Margins
Efficiency
Dividend
EBITDA margin
3.6%
Gross margin
87.6%
Net margin
-2.4%
Operating margin
-0.8%
Return on assets
-12.4%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-30.5%
Return on sales
-1.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LFMD stock price
How has the LifeMD stock price performed over time
Intraday
-0.18%
1 week
-3.1%
1 month
-19.02%
1 year
11.07%
YTD
13.54%
QTD
-17.23%
Financial performance
How have LifeMD's revenue and profit performed over time
Revenue
$245.56M
Gross profit
$215.05M
Operating income
-$2.03M
Net income
-$5.93M
Gross margin
87.6%
Net margin
-2.4%
LFMD's operating margin has soared by 93% year-on-year and by 75% since the previous quarter
LFMD's operating income has soared by 89% YoY and by 73% from the previous quarter
The net margin has surged by 82% year-on-year and by 48% since the previous quarter
LifeMD's net income has surged by 75% YoY and by 45% QoQ
Price vs fundamentals
How does LFMD's price correlate with its fundamentals
Growth
What is LifeMD's growth rate over time
Valuation
What is LifeMD stock price valuation
P/E
N/A
P/B
N/A
P/S
1.02
EV/EBIT
N/A
EV/EBITDA
28.43
EV/Sales
1.03
The EPS has soared by 71% YoY and by 39% from the previous quarter
LifeMD's equity has surged by 58% YoY and by 23% QoQ
The P/S is 46% below the 5-year quarterly average of 1.9 and 27% below the last 4 quarters average of 1.4
The revenue has grown by 38% YoY and by 4.9% from the previous quarter
Efficiency
How efficient is LifeMD business performance
The ROS has soared by 90% YoY and by 65% from the previous quarter
LFMD's ROA has soared by 74% year-on-year and by 37% since the previous quarter
Dividends
What is LFMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LFMD.
Financial health
How did LifeMD financials performed over time
LifeMD's total assets has increased by 15% YoY
The quick ratio has contracted by 14% YoY and by 5% from the previous quarter
LFMD's debt to equity has dropped by 150% year-on-year and by 15% since the previous quarter
LifeMD's equity has surged by 58% YoY and by 23% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.